Special Issues
Medicines publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Drug-Related Problems: Clinical Pharmacy and Safety of Pharmacotherapy
Deadline: 15 February 2026
Drug Abuse and Withdrawal Syndromes: From Addiction Pathways to Novel Interventions
Deadline: 31 January 2026
Clinical Psychopharmacology and Toxicology
Deadline: 30 November 2025
Frailty Syndrome in the Elderly: A Real Challenge for Our Society
Deadline: 31 March 2023
PROTAC—From Bench to Bed
Deadline: 31 January 2023
Perspective of Metabolism: Potential Therapeutic Targets of Metabolic Diseases such as Obesity-Associated Diabetes, Atherosclerosis and Fatty Liver
Deadline: 31 December 2022
COVID-19-Associated Diseases: The Uncertainty of Diagnosis and Treatment
Deadline: 31 December 2022
Feature Papers in Cancer Biology and Anticancer Therapeutics
Deadline: 31 May 2021
Recent Advances in Stem Cell Treatment
Deadline: 31 August 2020
Research Topics in Medicines and How Our Board Members Are Engaged in Them
Deadline: 31 July 2020
Biological Efficacy of Natural Products against Noncommunicable Diseases
Deadline: 30 June 2020
Pathogenesis and Treatment of Chronic Pruritus
Deadline: 31 January 2020
of 4

